PKY Pathkey.AI Ltd
Healthcare · Health Information Services
· website
$0.03
52wk 0.01 – 0.07
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Pathkey.AI Ltd
Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$36.05M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
1.41
EV / EBITDA
-6.38
Price / Book
14.50
ROE
-1,344.9%
Operating margin
-6,396.6%
Net margin
0.0%
Total cash
$580,841
Total debt
$0
Current ratio
2.44
Debt / Equity
—
Free cash flow
$-862,861
Avg volume
4.69M
Latest annual results
(FY ending 30 Jun 2025)
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS-0.01
- Free cash flow—
- Net debt—